Treatment of cutaneous tumors with topical 5% imiquimod cream
INTRODUCTION: There are various approaches to the treatment of cutaneous tumors; one of them is treatment with imiquimod, a synthetic toll-like receptor agonist with a low molecular weight that offers a topical, noninvasive, and non-surgical therapeutic option. The main objective of our study was to...
Main Authors: | Sabrina Sisto Alessi, Jose Antonio Sanches, Walmar Roncalli de Oliveira, Maria Cristina Messina, Eugenio Raul de Almeida Pimentel, Cyro Festa Neto |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier España
2009-01-01
|
Series: | Clinics |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322009001000005 |
Similar Items
-
Topical imiquimod in combination with brachytherapy for unresectable cutaneous melanoma scalp metastases
by: Jennifer E. Yeh, MD, PhD, et al.
Published: (2023-01-01) -
Successful treatment of giant basal cell carcinoma with topical imiquimod 5% cream with long term follow-up
by: M Chun-Guang, et al.
Published: (2014-01-01) -
Subclinical persistence of residual acral melanoma in situ after treatment with topical imiquimod and retinoid creams
by: Jenne P. Ingrassia, BA, et al.
Published: (2024-03-01) -
A case of topical imiquimod induced fatigue
by: Justin Raman, et al.
Published: (2022-11-01) -
Superficial basal cell carcinoma treated with curettage followed by topical imiquimod cream: A retrospective study
by: Andrew L. Ondo, MD, et al.
Published: (2024-03-01)